Corient Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.4M | Buy |
201,698
+95,148
| +89% | +$42.6M | 0.1% | 182 |
|
|
2025
Q1 | $51.7M | Sell |
106,550
-6,596
| -6% | -$3.2M | 0.08% | 215 |
|
|
2024
Q4 | $45.2M | Sell |
113,146
-16,119
| -12% | -$6.43M | 0.07% | 244 |
|
|
2024
Q3 | $60.1M | Sell |
129,265
-25,555
| -17% | -$11.9M | 0.09% | 206 |
|
|
2024
Q2 | $72.6M | Buy |
154,820
+2,281
| +1% | +$1.07M | 0.13% | 166 |
|
|
2024
Q1 | $63.6M | Buy |
152,539
+71
| +0% | +$29.6K | 0.11% | 188 |
|
|
2023
Q4 | $62M | Sell |
152,468
-7,776
| -5% | -$3.16M | 0.11% | 185 |
|
|
2023
Q3 | $55.7M | Sell |
160,244
-12,059
| -7% | -$4.19M | 0.13% | 172 |
|
|
2023
Q2 | $60.6M | Sell |
172,303
-3,362
| -2% | -$1.18M | 0.14% | 155 |
|
|
2023
Q1 | $55.3M | Buy |
175,665
+30,339
| +21% | +$9.56M | 0.15% | 149 |
|
|
2022
Q4 | $42M | Buy |
+145,326
| New | +$42M | 0.15% | 155 |
|